CAPR

5.94

5.41% -0.34

Dopo l'orario di chiusura: 5.96 0.02 +0.34%

Capricor Therapeutics Inc (CAPR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CAPR Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$6.28

Aprire:

$6.32

Volume 24 ore:

2.00M

Relative Volume:

0.82

Capitalizzazione di mercato:

$271.56M

Reddito:

$27.10M

Utile/perdita netta:

$-24.31M

Rapporto P/E:

-7.1566

EPS:

-0.83

Flusso di cassa netto:

$-33.33M

1 W Prestazione:

-5.11%

1M Prestazione:

-22.66%

6M Prestazione:

-56.64%

1 anno Prestazione:

+36.55%

Intervallo 1D:

$5.68

$6.32

Intervallo di 1 settimana:

$5.68

$6.43

Portata 52W:

$3.98

$23.40

Capricor Therapeutics Inc Stock (CAPR) Company Profile

Nome

Capricor Therapeutics Inc

Settore

Healthcare (1151)

Industria

Biotechnology (646)

Telefono

(310) 358-3200

Indirizzo

10865 ROAD TO THE CURE, SAN DIEGO, CA

Dipendente

160

Cinguettio

@Capricor

Prossima data di guadagno

2025-03-19

Ultimi documenti SEC

CAPR's Discussions on Twitter

Confronta CAPR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CAPR Capricor Therapeutics Inc	5.94	289.39M	27.10M	-24.31M	-33.33M	-0.83
VRTX Vertex Pharmaceuticals Inc	396.93	102.81B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	453.54	58.59B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	567.22	61.25B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	733.66	43.23B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	318.73	36.53B	3.81B	-644.79M	-669.77M	-6.24

Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-06-30	Iniziato	Alliance Global Partners	Buy
2025-06-26	Iniziato	B. Riley Securities	Buy
2025-05-20	Iniziato	Roth Capital	Buy
2024-10-21	Iniziato	Piper Sandler	Overweight
2024-05-17	Iniziato	Oppenheimer	Outperform
2024-01-05	Iniziato	Cantor Fitzgerald	Overweight
2022-10-26	Iniziato	Ladenburg Thalmann	Buy
2018-12-26	Downgrade	Maxim Group	Buy → Hold
2018-01-26	Reiterato	H.C. Wainwright	Buy
2017-09-15	Reiterato	H.C. Wainwright	Buy
2017-02-13	Ripresa	Rodman & Renshaw	Buy
2016-07-06	Ripresa	H.C. Wainwright	Buy
2016-06-15	Iniziato	ROTH Capital	Buy

Mostra tutto

Capricor Therapeutics Inc Borsa (CAPR) Ultime notizie

Sep 03, 2025

Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investor Alert: Deadline in Lawsuit on September 15, 2025 - openPR.com

Sep 03, 2025

Class Action Lawsuit Filed Against Capricor Therapeutics, Inc. (CAPR)Recover LossesContact Levi & Korsinsky Before September 15, 2025 - Barchart.com

Sep 03, 2025

Tools to assess Capricor Therapeutics Inc.’s risk profileMarket Growth Report & Growth Oriented Trade Recommendations - Newser

Sep 03, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - FinancialContent

Sep 03, 2025

CAPRICOR ALERT: Bragar Eagel & Squire, P.C. Announces that - GlobeNewswire

Sep 03, 2025

4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week - Benzinga

Sep 03, 2025

Volatility clustering patterns for Capricor Therapeutics Inc.Market Volume Summary & Technical Pattern Alert System - Newser

Sep 03, 2025

Short interest data insights for Capricor Therapeutics Inc.Volume Spike & Fast Exit Strategy with Risk Control - Newser

Sep 03, 2025

Nuveen LLC Acquires Shares of 89,141 Capricor Therapeutics, Inc. $CAPR - Defense World

Sep 03, 2025

Long term hold vs stop loss in Capricor Therapeutics Inc.Weekly Profit Report & Expert Curated Trade Setup Alerts - Newser

Sep 03, 2025

Real time social sentiment graph for Capricor Therapeutics Inc.2025 Major Catalysts & Fast Gain Swing Trade Alerts - Newser

Sep 03, 2025

Sep 02, 2025

מועד אחרון לתביעה נגד CAPR: רוזן, משרד עורכי דין מהימן ומוביל, מעודד משקיעים ב- Capricor Therapeutics, Inc. עם הפסדים של יותר מ-100 אלף דולר להבטיח ייעוץ לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך - GlobeNewswire Inc.

Sep 02, 2025

CAPR DEADLINE: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CAPR - GlobeNewswire Inc.

Sep 02, 2025

Capricor Therapeutics, Inc. Investors: Please contact the - GlobeNewswire

Sep 02, 2025

Chart based exit strategy for Capricor Therapeutics Inc.Earnings Growth Report & Free Community Consensus Stock Picks - Newser

Sep 02, 2025

How to forecast Capricor Therapeutics Inc. trends using time seriesJuly 2025 EndofMonth & Capital Protection Trading Alerts - Newser

Sep 02, 2025

INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of - GlobeNewswire

Sep 02, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc.CAPR - FinancialContent

Sep 02, 2025

CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) SHAREHOLDER - GlobeNewswire

Sep 02, 2025

Market Overview: Can Capricor Therapeutics Inc. expand into new marketsJuly 2025 Macro Moves & Free Community Consensus Stock Picks - خودرو بانک

Sep 02, 2025

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Sep 02, 2025

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Sep 02, 2025